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Rubraxanthone is one of antibacterial  and antioxidant compound 
which is isolated from stem bark of mangosteen (Garcinia 
mangostana Linn.). The precise method for analysis of plant 
constituents is normally a reverse-phase high performance liquid 
chromatographic (RP-HPLC). Development and validation of a 
RP-HPLC method for chromatographic separation was carried out 
on a reversed-phase column Shimadzu ®  Shimp-pack VP – ODS 
(4.6x250mm) using an isocratic mobile phase of  0.4% formic 
acid - acetonitrile at  a flow rate 1mL min-1, and detection was  
with a UV detector. The linearity of  the proposed method was 
found in the range of 2.5-25μg/mL-1 with regression coefficient 
0.999. Intraday precision studies showed the relative standard 
deviation ≤1.58% and  inter-day ≤3.20%. Accuracy of the 
method was determined by a recovery study conducted at 3 
different levels, and the average recovery was 102.18%. The 
Limit of Detection Limit of Quantitation (LOQ) and were 0.47 and 
1.56μg/mL-1.The contents of rubraxanthon in the crude was 
0.23±0.07%w/w. 
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INTRODUCTION 
Garcinia mangostana Linn. Guttiferae, 
known as “queen of fruits”  is cultivated in the 
tropical rainforest of some Southeast Asian 
nations like Indonesia, Malaysia, Sri Lanka, 
Philippines, and Thailand. The bark of G. 
mangostana  is one of the sources for the 
extraction of rubraxanthone. Rubraxanthone is 
one class of xanthone compounds that have 
pharmacology activity as antibacterial agent, 
where these compounds have been shown to 
inhibit the growth of Staphylococcus aureus 
(Iimuna, 1996), Trichophyton mentagrophytes, and 
Microsporum gypseum, Staphylococcus epidermidis 
(Pattalung, 1988), Micrococcus luteus, Pseudomonas 
aeruginosa , Escherichia coli and  Helicobacter pyroli 
(Dachriyanus, 2003). In addition, rubraxanthone 
also been reported as antiplatelet (Jantan, 2002), 
and an antioxidant (Dachriyanus, 2003). 
It is well accepted that for evaluating the 
quality of herbal medicines, it is necessary to 
standardize the content of the active principles. 
Standardization and analysis of the active 
principles of the herbal medicine is always 
difficult.   Quantitative  determination of  active  
principles in the herbal medicine preparation 
required optimal separation techniques by 
which these compounds are separated with the 
highest resolution and the least interferences 
from each other. Herbal medicine has been 
enjoying renaissance among the customers 
throughout the world. However, one of the 
impediments in the acceptance of herbal 
products worldwide is the lack of standard 
quality control profiles (Shinde, 2009).  
Chemical and chromatographic 
techniques may be used to aid in the 
identification of an herbal material or extract. 
Chromatographic techniques such as HPLC, 
TLC, GC and capillary electrophoresis and 
spectroscopic methods such as IR, NMR and 
UV may also be used for fingerprinting (Patra, 
2010). In order to control the quality of herbal 
drugs in a better way, we must develop new 
techniques and terms to the maximum extent. 
The development and validation of an efficient 
analytical method is an integral part of the 
quality control of the source material, to 
guarantee the safety and effectiveness of the 
resulting compound (Hefnawy, 2006). 
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Thus, considering the pharmacological 
potential of bark extract of G. mangostana and 
the lack of specifications for the quality control 
of this plant raw material, which is a pre-
requisite for the production and registration of 
phytomedicines. The objective of the present 
study was to develop and validate a method for 
the separation and quantitative analysis of 
rubraxanthone by RP-HPLC. Furthermore, no 
previous study described for   the analysis of 
Rubraxanthone in stem bark extract of 
G.mangostana. So, it will provide the scientific 
basis for the quality control of extracts 






















Figure 1. Rubraxanthone. 
 
There was no rubraxanthone available 
for standard compound, therefore in this study, 
rubraxanthone (Figure 1) was isolated from 
metanol extract of bark of G. cowa  using 
chromato-graphic techniques (column 
chromatography, TLC,) and its structure was 
confirmed on the basis of spectral data. 
 
MATERIALS AND METHODS 
Chemical and reagents 
All reagents and solvents were analytical 
and HPLC grades (merck), except formic acid. 




Stem bark of G. mangostana was collected 
from Lubuk Alung, West Sumatra. The plants 
sample were identified by taxonomist from 
Herbarium ANDA Andalas University. The 
bark were cut into small pieces and dried in a 
hot oven at 50°C for 72h. The dried samples 
were ground into powder and passed through a 
sieve (20 meshes).  
 
Isolation of rubraxanthone  
Ground air-dried stem bark (2.2kg) was 
percolated with methanol (10L).  The extract 
was evaporated to dryness under reduced 
pressure and the dark mass (113.54g) was 
extracted in turn with hexane (4x100mL) which 
on evaporation yielded a gum (5.7g), ethyl 
acetate (11x600mL), which on evaporation 
yielded a gum (43.0g) and butanol (8x150mL) 
which on evaporation yielded a gum (45.0g). 
The ethyl acetate fraction (40g) was          
then subjected to column chromatography 
(5.0x80cm). Column chromatography (CC) was 
carried out using silica gel Merck  7734 and 
successively eluted with hexane followed by 
hexane : EtOAc mixture in step gradient 
polarity, and finally washed with methanol to 
give 50 fractions (50mL each) designated as 
fraction A (1-6, 0.25g), B (7-14, 0.80g), C (15-
28, 12.5g), D (29-39, 2g), E (40-50, 11g).  
Fraction C was further fractionated by VLC, 
eluting with hexane, mixture of hexane and 
EtOAc in step gradient polarity manner, and 
finally with MeOH to afford four fractions, 
(CA-CD) . fraction CB (4g) was separated by 
silica gel CC, eluting with hexane–EtOAc, 9:1 
to give six sub-fractions, CB1–CB6.  
Separation of sub-fraction fraction CB4 
(800mg) was performed by CC over silica gel, 
eluting with  hexane–EtOAc, 9:1 to afford 
unpurified rubraxanthone (445mg). Purifying 
this fraction by recrystallisation with EtOac and 
hexane, yielded 250 mg of rubraxanthone. 
Fraction CC (1g) was chromatographed on 
silica gel column (2.5x15cm) eluted with hexane 
and EtOAc mixture in step gradient polarity 
manner. The combined fractions 15-23 
(450mg) was again rechromatographed on silica 
gel column (1.5x45) and eluted with n hexane 
and EtOAc mixture in step gradient polarity to 
give fourteen 15mL fractions of which fraction 
2-8 were combined and gave 145mg of yellow 
solid product. Purifying this product by 
recrystalisation with EtOAc and hexane yielded 
rubraxanthone (93 mg) as yellow needles, m.p. 
207-209°C. UV MeOH max (log ε)nm: 203 
(4.54), 241 (4.50), 312 ( 4.32), IR max (KBr)cm-
1: 3425, 3240, 2965, 2855, 1641, 1162, 827; 
EIMS: m/z 410 [M]+• (23%), 341(100), 299(25), 
69(33). High-resolution EIMS found: 410.1727 
(calculated for C24H26O6, m/z 410.1729).   
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1H NMR (500 MHz, CD3OD):   6.72 
(1H, s, H-5), 6.21 (1H, d, J= 2.0 Hz,, H-4), 6.18 
(1H, d, J= 2.0 Hz, H-2), 5.20 ( 1H, t, J= 7.0 Hz, 
H-6’), 5.01 (1H, t, J= 7.0 Hz, H-2’), 4.07 (2H, d, 
J= 7.0 Hz, H-1’), 3.4 (3H, s, 7-OMe), 2.05 (2H, 
t, J= 7.0 Hz, H-5’), 1.98 (2H, t, J= 7.0 Hz, H-
4’),1.81 (3H, s, H-8’), 1,55 (3H, s, H-10’), 1.52 
(3H, s, H-9’).  
13C NMR (125 MHz, CD3OD): 182.00 
(C-9), 164.8 (C-1), 163.6 (C-3), 157.3 (C-6), 
156.9 (C-5a), 155.7 (C-4a), 143.8 (C-7), 137.5 
(C-8), 134.3 (C-3’), 130.8 (C-7’), 124.3 (C-2’), 
124.0 (C-6’), 111.0 (C-8a), 102.8 (C-9a), 101.7 
(C-5), 97.6 (C-2), 92.9 (C-4), 60.2 (7-OMe), 39.6 
(C-4’), 26.4 (C-5’), 25.8 (C-1’), 24.6 (C-9’), 16.5 
(C-10’), 15.5 (C-8’).    
 
Instrumentation and chromatographic 
condition 
HPLC method was performed on a 
Shimadzu (Kyoto, Japan) liquid chromatograph 
system, equipped with a model LC-20 AD 
pump, UV-Vis SPD M-20A Diode detector.  
Separation was performed in a reversed-phase 
column Shimadzu® Shimp-pack VP-ODS ( 
4.6x250mm).The elution was carried out with 
isocratic solvent  using 0.4% v/v  formic acid - 
acetonitrile with  a flow rate 1mL menit -1. The 
mobile phase was prepared daily, filtered through 
a 0.45μm and sonicated before use. Total running 
time was 20min and the sample injection volume 
was 10μL while the wavelength of the UV-VIS 
detector was set at 243nm. The compound was 
quantified using CLASS VP software. 
 
 




Figure 3.  FTIR spectrum of rubraxanthone in KBr plate 
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Preparation of standard solutions 
A stock solution of rubraxanthone 
reference standard was prepared by dissolving 
an accurately weighed 10mg of rubraxanthon in 
10mL of methanol in a volumetric flask. 
Various concentrations of the standard solution 
were diluted to obtain final concentrations at 
2.5: 5: 10: 12.5: and 25μg/mL-1 with methanol. 
 
Preparation of sample solutions 
The powder bark of G. mangostana (100g) 
was separately placed into a thimble and was 
extracted with 1000mL of 95% ethanol at room 
temperature for 18h. Each extract was filtered 
through a Whatman no. 1 filter paper by 
suction. The filtrate was concentrated under 
reduced pressure at 50ºC using a rotary vacuum 
evaporator. The final weight of the crude 
extract was weighed and calculated for the 
yield. The extraction of each sample was done 
in triplicate. 
Each dried extract (10mg) was accurately 
weighed and transferred to a 10mL volumetric 
flask. Methanol was added to volume (final 
concentration 1.000μg/mL-1). Aliquot of the 
solution (2.5mL) was diluted with methanol in a 
10mL volumetric flask to make a concentration 
of 250μg/mL-1. Prior to analysis, the solutions 
were filtered through 0.45μm membrane filters. 
 
Quantitative analysis of rubraxanthon 
content 
Determination of rubraxanthon  content 
was carried out by HPLC under the same 
condition as the proposed method. 
Rubraxanthon content in the extract was 
calculated using its calibration curve with 
regarding to the dilution factor. The contents 
of rubraxanthon in the extract was expressed as 
gram per 100g of the extract. Each 
determination was carried out in triplicate. 
 
Validation of the method 
Validation of the analytical method was 
done according to the International Conference 
on Harmonization guideline (ICH, 1995). The 
method was validated for linearity, precision, 
and accuracy, limit of detection (LOD) and 
limit of quantitation (LOQ). 
 
Linearity 
Linearity was determined by using 
rubraxanthon standard solution in the 
concentration range were  of 2.5–25ug/mL-1        
in methanol, each  of the standard solution         
was prepared (n=3). The calibration              
curves were obtained by plotting the peak area 




         
         Figure 4. EI-MS spectrum of rubraxanthone 
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Precision 
The precision was determined by 
analyzing 2.5:10 and 25μg/mL-1 of standard 
solution of rubraxanthon (n=3). Intra-                 
and inter-day assay precision were determined 
as relative standard deviation (RSD). Intra-         
day precission (repeatability) involved here 
replicates per day and inter-day (intermediate) 




The accuracy of the method was tested 
by performing recovery studies. Three different 
levels concentration (2.5:10 and 25ug/mL-1) of 
the standard solution in methanol) were added 
to the sample solution (10.43μg/mL-1) and 
analyzed by the proposed RP HPLC method. 
The recovery and average recovery were 
calculated. Three determinations were 
performed for each concentration level. 
 
LOD and LOQ 
According to ICH (1995), technical 
requirements for the registration of pharma-
ceuticals for human use recommend-dations, 
the approach based on SD of the response and 
the slope were used for determining the 
detection and quantitation limits. 
RESULTS AND DISCUSSION 
HPLC method with isocratic elution was 
developed for the quantification of 
rubraxanthon in stem bark extracts of G. 
mangostana.. Optimization of mobile phase was 
performed based on asymmetric factor and 
peak area obtained. Different mobile phases 
were used but satisfactory separation, well 
resolved and good symmetrical peaks               
were obtained with the mobile phase 0.4% 
formic acid and acetonitrile (25:75%v/v).         
The retention time of rubraxanthon  was  
found to be 12.121 min in relation to 
asymmetry, the peaks showed an asymmetric 
factor was at 0.815 (<2.5), which indicates a 
good baseline (Figure 6). The number                  
of theoretical plates was found to be              
14296 (>2500), which indicates efficient 
performance of the column. The UV             
spectra of Rubraxanthone showed the 
maximum absorption at 243nm. Thus, it             
was chosen as detection wave length in liquid 
chromatography. 
  The calibration curve for rubraxanthon 
was obtained by plotting the peak area              
ratio versus the concentration of rubraxanthon  
over the range of 2.5-25μg/mL-1, and it             
was    found    to   be    linear    with    r=0.999.    
         
 
 
Figure 5. 1H-NMR spectrum of rubraxanthone in CD3OD 
 
Determination and Quantification of Rubraxanthone 
Volume 25 Issue 4 (2014) 242 
The regression equation of rubraxanthon 
concentration over its peak area ratio was 
found to be y=156554 x –6185, where x is the 
concentration of rubraxanthon and y is the 
respective peak area. The limit of detection and 
limit of quantification for rubraxanthon was 
found to be 0.47 and 1.56μg/mL-1, indicates 
the sensitivity of the method. The system 
suitability and validation parameters were given 
in (Table II) 
The intra-day precision (repeatability) of 
the assay was determined by analysis of 3 
different concentration (2.5, 10, and 25μg/mL-1) 
of standard rubraxanthon on the same day. For 
determination of inter-day (intermediate) 
precision, the samples were analysed on 3 
different days. In the precision study,  
percentage relative standard deviation of the 
peak area of rubraxanthon are shown in table 
II. These values were within limits <5% 
(AOAC, 2002).  
The accuracy of the method was 
determined by adding accurate amount of 
rubraxanthon standard to quantified 
rubraxanthone in extract samples. The mean 
values of the percentage analytical recoveries 
for    the concentration of 2.5, 10 and 25μg/mL-1  
of rubraxanthon were 99.39, 104.47 and 
102.69% respectively (Table III).  AOAC 
(2002) recommended that percentage of 
recovery in the range of 80-120%. The results 
showed the percentage of recovery fulfilled this 
recommendation. The high percentage of 
recovery of rubraxanthon indicates that the 
proposed method is highly accurate.  
The RSD values for accuracy and 
precision studies obtained were less than 5%. It 
can be concluded that developed method was 
accurate and precise. The limit of detection and 
limit of quantification for rubraxanthon was 
found to be 0.47 and 1.56μg/mL-1, indicates 
the sensitivity of the method. 
Rubraxanthon content in the samples          
of stem bark extracts G. mangostana which 
obtained from Lubuk Alung, West          
Sumata determined by the developed HPLC 
was 0.23±0.07 %W/W respectively. HPLC 
chromatograms of extracts showed similar 
pattern with a  peak rubraxanthon at retention 
time of 12.12min (Figure 6). The identity of the 
peak of rubraxanthon in the sample 
chromatograms was confirmed by spiking with 






Figure 6. 13C-NMR spectrum of  rubraxanthone in CD3OD. 
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Figure 7. HPLC fingerprint of G. mangostana bark extract (showing a chemical structure of 
identified chemicals) 
 




Linear range (µg/mL-1) 2.5 -25 
Regression equation* y = 156554 x – 6185 
Correlation coefficient  0.999 
LOD  (µg/mL) 0.47 
LOQ  (µg/mL) 1.56 
  
*  x is the concentration of rubraxanthon in µg mL-1; y is the peak area at 243 nm 
       
 
Table II. Precision study of rubraxanthone by the proposal HPLC method  
 
  Peak area RSD Rubraxanthone RSD 
    (%) (ug/mL-1) (%) 
Intra-day precision * 390207±6247 1.6 2.532±0.040 1.58 
Inter-day precision**  383567±7237 4.5 2.489±0.039 3.20 
 
The results are mean ± SD of 9 determination. * 3 replicates were assayed  
on the same day; **3 replicates were assayed on 3 different days  
 
 









A 2.5 2.48±0.07 99.39±2.79 
B 10  10.47±0.22 104.47±2.19 
C 25 25.67±0.28 102.69±1.13 
 
A - Low concentration, B - intermediate concentration and C - high  concentration for range calibration. 
The result are mean ± SD of 3 experiments 
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CONCLUSIONS 
The proposed HPLC method promoted 
high precision, sensitivity and accuracy for 
quality control of extract  of bark G. mangostana  
This proposed method will be useful for 
quantitative analysis in standardization and 
quality assessment of extract of bark G. 
mangostana for pharmaceutical uses. 
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